Details of the Drug Reposition

General Information of This Drug (ID: DMS4H1J)

• Drug Name: BMS-936564 (DMS4H1J)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Acute myeloid leukaemia	DIS0BM1I	2A60	Phase 1	[1]
B-cell chronic lymphocytic leukaemia	DISNHN2M	2A82.00	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT02305563) Phase 1 Study of BMS-936564. U.S. National Institutes of Health.